HEADER TRANSCRIPTION 01-JUN-04 1THN TITLE CRYSTAL STRUCTURES OF THE ADP AND ATP BOUND FORMS OF THE BACILLUS TITLE 2 ANTI-SIGMA FACTOR SPOIIAB IN COMPLEX WITH THE ANTI-ANTI-SIGMA TITLE 3 SPOIIAA: INHIBITORY COMPLEX WITH ADP, CRYSTAL FORM I COMPND MOL_ID: 1; COMPND 2 MOLECULE: ANTI-SIGMA F FACTOR; COMPND 3 CHAIN: A, C; COMPND 4 SYNONYM: STAGE II SPORULATION PROTEIN AB; COMPND 5 EC: 2.7.1.37; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: ANTI-SIGMA F FACTOR ANTAGONIST; COMPND 9 CHAIN: B, D; COMPND 10 SYNONYM: STAGE II SPORULATION PROTEIN AA; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: GEOBACILLUS STEAROTHERMOPHILUS; SOURCE 3 ORGANISM_TAXID: 1422; SOURCE 4 GENE: SPOIIAB; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PET21A; SOURCE 10 MOL_ID: 2; SOURCE 11 ORGANISM_SCIENTIFIC: GEOBACILLUS STEAROTHERMOPHILUS; SOURCE 12 ORGANISM_TAXID: 1422; SOURCE 13 GENE: SPOIIAA; SOURCE 14 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 15 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 16 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 17 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 18 EXPRESSION_SYSTEM_PLASMID: PET21A KEYWDS SPOIIAB, SPOIIAA, ANTI-SIGMA, ANTI-ANTI-SIGMA, SPORULATION, SERINE KEYWDS 2 KINASE, TRANSCRIPTION EXPDTA X-RAY DIFFRACTION AUTHOR S.MASUDA,K.S.MURAKAMI,S.WANG,C.A.OLSON,J.DONIGAN,F.LEON,S.A.DARST, AUTHOR 2 E.A.CAMPBELL REVDAT 4 23-AUG-23 1THN 1 REMARK SEQADV REVDAT 3 24-FEB-09 1THN 1 VERSN REVDAT 2 20-JUL-04 1THN 1 JRNL REVDAT 1 15-JUN-04 1THN 0 JRNL AUTH S.MASUDA,K.S.MURAKAMI,S.WANG,C.A.OLSON,J.DONIGIAN,F.LEON, JRNL AUTH 2 S.A.DARST,E.A.CAMPBELL JRNL TITL CRYSTAL STRUCTURES OF THE ADP AND ATP BOUND FORMS OF THE JRNL TITL 2 BACILLUS ANTI-SIGMA FACTOR SPOIIAB IN COMPLEX WITH THE JRNL TITL 3 ANTI-ANTI-SIGMA SPOIIAA. JRNL REF J.MOL.BIOL. V. 340 941 2004 JRNL REFN ISSN 0022-2836 JRNL PMID 15236958 JRNL DOI 10.1016/J.JMB.2004.05.040 REMARK 2 REMARK 2 RESOLUTION. 2.50 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES,PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH & HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.50 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 30.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 98.1 REMARK 3 NUMBER OF REFLECTIONS : 24658 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.224 REMARK 3 FREE R VALUE : 0.265 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : 1252 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3892 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 59 REMARK 3 SOLVENT ATOMS : 53 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.009 REMARK 3 BOND ANGLES (DEGREES) : NULL REMARK 3 DIHEDRAL ANGLES (DEGREES) : NULL REMARK 3 IMPROPER ANGLES (DEGREES) : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : NULL REMARK 3 KSOL : NULL REMARK 3 BSOL : NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1THN COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 03-JUN-04. REMARK 100 THE DEPOSITION ID IS D_1000022649. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-APR-03 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 11 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X25 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25047 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.500 REMARK 200 RESOLUTION RANGE LOW (A) : 30.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.1 REMARK 200 DATA REDUNDANCY : 4.900 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.03100 REMARK 200 FOR THE DATA SET : 39.5600 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.50 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.55 REMARK 200 COMPLETENESS FOR SHELL (%) : 91.8 REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : 0.11000 REMARK 200 FOR SHELL : 11.27 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: CNS REMARK 200 STARTING MODEL: PDB ENTRY ID1L0O, PDB ENTRY ID 1H4Y REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 55.30 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.75 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M CAPS, 6% DMF, 2.0M LITHIUM REMARK 280 SULFATE, PH 11, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 295.5K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 41 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y,X,Z+1/4 REMARK 290 4555 Y,-X,Z+3/4 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 132.83600 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 66.41800 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 199.25400 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE ASYMMETRIC UNIT CONTAINS ONE BIOLOGICAL ASSEMBLY OF 2AB/ REMARK 300 2AA (A TETRAMER OR 2 HETERODIMERS) REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C, D REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 GLY A 138 REMARK 465 ILE A 139 REMARK 465 HIS A 140 REMARK 465 HIS A 141 REMARK 465 HIS A 142 REMARK 465 HIS A 143 REMARK 465 HIS A 144 REMARK 465 HIS A 145 REMARK 465 MET B 1 REMARK 465 ALA B 116 REMARK 465 MET C 1 REMARK 465 GLY C 138 REMARK 465 ILE C 139 REMARK 465 HIS C 140 REMARK 465 HIS C 141 REMARK 465 HIS C 142 REMARK 465 HIS C 143 REMARK 465 HIS C 144 REMARK 465 HIS C 145 REMARK 465 MET D 1 REMARK 480 REMARK 480 ZERO OCCUPANCY ATOM REMARK 480 THE FOLLOWING RESIDUES HAVE ATOMS MODELED WITH ZERO REMARK 480 OCCUPANCY. THE LOCATION AND PROPERTIES OF THESE ATOMS REMARK 480 MAY NOT BE RELIABLE. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 480 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 480 M RES C SSEQI ATOMS REMARK 480 GLU A 16 CG CD OE1 OE2 REMARK 480 ASP A 31 CG OD1 OD2 REMARK 480 MET A 34 CB CG REMARK 480 ASN A 57 CB CG OD1 ND2 REMARK 480 ASN A 58 OD1 ND2 REMARK 480 GLU A 71 CD OE1 OE2 REMARK 480 ASP A 72 CG OD1 OD2 REMARK 480 GLU A 91 CB CG CD OE1 OE2 REMARK 480 GLU A 102 CB CG CD OE1 OE2 REMARK 480 LEU A 103 CB CG CD1 CD2 REMARK 480 LYS A 128 CB CG CD CE NZ REMARK 480 LYS A 135 CE NZ REMARK 480 GLN B 70 CG CD OE1 NE2 REMARK 480 LYS B 72 CE NZ REMARK 480 PHE B 97 CD1 CD2 CE1 CE2 CZ REMARK 480 LYS B 98 CD CE NZ REMARK 480 ILE B 99 CG1 CD1 REMARK 480 ARG B 101 CG CD NE REMARK 480 THR C 49 OG1 CG2 REMARK 480 GLU C 71 CG CD OE1 OE2 REMARK 480 GLU C 90 CG CD OE1 OE2 REMARK 480 LYS C 100 CB CG CD CE NZ REMARK 480 LYS C 128 CB CG CD CE NZ REMARK 480 LEU D 65 CG CD1 CD2 REMARK 480 ARG D 89 CB CG CD NE CZ NH1 NH2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OE2 GLU B 103 OE1 GLU C 90 4564 2.12 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU B 48 CA - CB - CG ANGL. DEV. = 19.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASN A 3 123.07 176.70 REMARK 500 ASN A 57 48.93 30.22 REMARK 500 ASN A 61 2.38 -68.96 REMARK 500 ASP A 72 -136.92 50.47 REMARK 500 ARG A 93 5.88 -69.84 REMARK 500 GLU A 104 43.17 75.94 REMARK 500 LYS B 10 79.86 -104.42 REMARK 500 GLN B 11 -128.71 76.63 REMARK 500 ASP B 57 -150.74 -111.00 REMARK 500 GLU C 14 28.37 -72.90 REMARK 500 ASP C 31 66.51 62.54 REMARK 500 HIS C 54 -88.95 -106.65 REMARK 500 GLU C 71 141.72 -170.42 REMARK 500 PRO C 95 136.07 -38.60 REMARK 500 LEU C 96 -5.01 77.79 REMARK 500 LYS C 100 57.13 -111.28 REMARK 500 LEU C 103 41.17 -79.52 REMARK 500 GLU C 104 39.59 35.74 REMARK 500 ASN C 127 -0.49 57.04 REMARK 500 GLN D 11 -123.86 63.58 REMARK 500 PHE D 55 126.41 170.18 REMARK 500 PHE D 97 9.53 -68.48 REMARK 500 ILE D 99 -57.87 -142.00 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ADP A 200 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE ADP C 201 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE DMF A 201 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1TH8 RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURES OF THE ADP AND ATP BOUND FORMS OF THE BACILLUS REMARK 900 ANTI-SIGMA FACTOR SPOIIAB IN COMPLEX WITH THE ANTI-ANTI- REMARK 900 SIGMASPOIIAA-INHBITORY COMPLEX, CRYSTAL FORM II REMARK 999 REMARK 999 SEQUENCE REMARK 999 THE DISCREPANCIES IN BOTH CHAINS ARE DUE TO STRAIN REMARK 999 VARIATION. DBREF 1THN A 1 136 UNP O32727 SP2AB_BACST 1 136 DBREF 1THN B 1 116 UNP O32726 SP2AA_BACST 1 116 DBREF 1THN C 1 136 UNP O32727 SP2AB_BACST 1 136 DBREF 1THN D 1 116 UNP O32726 SP2AA_BACST 1 116 SEQADV 1THN MET A 34 UNP O32727 THR 34 SEE REMARK 999 SEQADV 1THN HIS A 137 UNP O32727 INSERTION SEQADV 1THN GLY A 138 UNP O32727 INSERTION SEQADV 1THN ILE A 139 UNP O32727 INSERTION SEQADV 1THN HIS A 140 UNP O32727 INSERTION SEQADV 1THN HIS A 141 UNP O32727 INSERTION SEQADV 1THN HIS A 142 UNP O32727 INSERTION SEQADV 1THN HIS A 143 UNP O32727 INSERTION SEQADV 1THN HIS A 144 UNP O32727 INSERTION SEQADV 1THN HIS A 145 UNP O32727 INSERTION SEQADV 1THN MET C 34 UNP O32727 THR 34 SEE REMARK 999 SEQADV 1THN HIS C 137 UNP O32727 INSERTION SEQADV 1THN GLY C 138 UNP O32727 INSERTION SEQADV 1THN ILE C 139 UNP O32727 INSERTION SEQADV 1THN HIS C 140 UNP O32727 INSERTION SEQADV 1THN HIS C 141 UNP O32727 INSERTION SEQADV 1THN HIS C 142 UNP O32727 INSERTION SEQADV 1THN HIS C 143 UNP O32727 INSERTION SEQADV 1THN HIS C 144 UNP O32727 INSERTION SEQADV 1THN HIS C 145 UNP O32727 INSERTION SEQADV 1THN VAL B 13 UNP O32726 GLU 13 SEE REMARK 999 SEQADV 1THN GLU B 29 UNP O32726 ASN 29 SEE REMARK 999 SEQADV 1THN LEU B 30 UNP O32726 CYS 30 SEE REMARK 999 SEQADV 1THN ARG B 31 UNP O32726 MET 31 SEE REMARK 999 SEQADV 1THN GLU B 32 UNP O32726 ASN 32 SEE REMARK 999 SEQADV 1THN GLN B 33 UNP O32726 LYS 33 SEE REMARK 999 SEQADV 1THN VAL B 34 UNP O32726 CYS 34 SEE REMARK 999 SEQADV 1THN THR B 35 UNP O32726 ARG 35 SEE REMARK 999 SEQADV 1THN ASP B 36 UNP O32726 MET 36 SEE REMARK 999 SEQADV 1THN VAL B 37 UNP O32726 CYS 37 SEE REMARK 999 SEQADV 1THN ASN B 40 UNP O32726 LYS 40 SEE REMARK 999 SEQADV 1THN VAL D 13 UNP O32726 GLU 13 SEE REMARK 999 SEQADV 1THN GLU D 29 UNP O32726 ASN 29 SEE REMARK 999 SEQADV 1THN LEU D 30 UNP O32726 CYS 30 SEE REMARK 999 SEQADV 1THN ARG D 31 UNP O32726 MET 31 SEE REMARK 999 SEQADV 1THN GLU D 32 UNP O32726 ASN 32 SEE REMARK 999 SEQADV 1THN GLN D 33 UNP O32726 LYS 33 SEE REMARK 999 SEQADV 1THN VAL D 34 UNP O32726 CYS 34 SEE REMARK 999 SEQADV 1THN THR D 35 UNP O32726 ARG 35 SEE REMARK 999 SEQADV 1THN ASP D 36 UNP O32726 MET 36 SEE REMARK 999 SEQADV 1THN VAL D 37 UNP O32726 CYS 37 SEE REMARK 999 SEQADV 1THN ASN D 40 UNP O32726 LYS 40 SEE REMARK 999 SEQRES 1 A 145 MET ARG ASN GLU MET HIS LEU GLN PHE SER ALA ARG SER SEQRES 2 A 145 GLU ASN GLU SER PHE ALA ARG VAL THR VAL ALA ALA PHE SEQRES 3 A 145 VAL ALA GLN LEU ASP PRO THR MET ASP GLU LEU THR GLU SEQRES 4 A 145 ILE LYS THR VAL VAL SER GLU ALA VAL THR ASN ALA ILE SEQRES 5 A 145 ILE HIS GLY TYR ASN ASN ASP PRO ASN GLY ILE VAL SER SEQRES 6 A 145 ILE SER VAL ILE ILE GLU ASP GLY VAL VAL HIS LEU THR SEQRES 7 A 145 VAL ARG ASP GLU GLY VAL GLY ILE PRO ASP ILE GLU GLU SEQRES 8 A 145 ALA ARG GLN PRO LEU PHE THR THR LYS PRO GLU LEU GLU SEQRES 9 A 145 ARG SER GLY MET GLY PHE THR ILE MET GLU ASN PHE MET SEQRES 10 A 145 ASP GLU VAL ILE VAL GLU SER GLU VAL ASN LYS GLY THR SEQRES 11 A 145 THR VAL TYR LEU LYS LYS HIS GLY ILE HIS HIS HIS HIS SEQRES 12 A 145 HIS HIS SEQRES 1 B 116 MET SER LEU ALA ILE ASP LEU GLU VAL LYS GLN ASP VAL SEQRES 2 B 116 LEU ILE VAL ARG LEU SER GLY GLU LEU ASP HIS HIS THR SEQRES 3 B 116 ALA GLU GLU LEU ARG GLU GLN VAL THR ASP VAL LEU GLU SEQRES 4 B 116 ASN ARG ALA ILE ARG HIS ILE VAL LEU ASN LEU GLY GLN SEQRES 5 B 116 LEU THR PHE MET ASP SER SER GLY LEU GLY VAL ILE LEU SEQRES 6 B 116 GLY ARG TYR LYS GLN ILE LYS ASN VAL GLY GLY GLN MET SEQRES 7 B 116 VAL VAL CYS ALA VAL SER PRO ALA VAL LYS ARG LEU PHE SEQRES 8 B 116 ASP MET SER GLY LEU PHE LYS ILE ILE ARG VAL GLU ALA SEQRES 9 B 116 ASP GLU GLN PHE ALA LEU GLN ALA LEU GLY VAL ALA SEQRES 1 C 145 MET ARG ASN GLU MET HIS LEU GLN PHE SER ALA ARG SER SEQRES 2 C 145 GLU ASN GLU SER PHE ALA ARG VAL THR VAL ALA ALA PHE SEQRES 3 C 145 VAL ALA GLN LEU ASP PRO THR MET ASP GLU LEU THR GLU SEQRES 4 C 145 ILE LYS THR VAL VAL SER GLU ALA VAL THR ASN ALA ILE SEQRES 5 C 145 ILE HIS GLY TYR ASN ASN ASP PRO ASN GLY ILE VAL SER SEQRES 6 C 145 ILE SER VAL ILE ILE GLU ASP GLY VAL VAL HIS LEU THR SEQRES 7 C 145 VAL ARG ASP GLU GLY VAL GLY ILE PRO ASP ILE GLU GLU SEQRES 8 C 145 ALA ARG GLN PRO LEU PHE THR THR LYS PRO GLU LEU GLU SEQRES 9 C 145 ARG SER GLY MET GLY PHE THR ILE MET GLU ASN PHE MET SEQRES 10 C 145 ASP GLU VAL ILE VAL GLU SER GLU VAL ASN LYS GLY THR SEQRES 11 C 145 THR VAL TYR LEU LYS LYS HIS GLY ILE HIS HIS HIS HIS SEQRES 12 C 145 HIS HIS SEQRES 1 D 116 MET SER LEU ALA ILE ASP LEU GLU VAL LYS GLN ASP VAL SEQRES 2 D 116 LEU ILE VAL ARG LEU SER GLY GLU LEU ASP HIS HIS THR SEQRES 3 D 116 ALA GLU GLU LEU ARG GLU GLN VAL THR ASP VAL LEU GLU SEQRES 4 D 116 ASN ARG ALA ILE ARG HIS ILE VAL LEU ASN LEU GLY GLN SEQRES 5 D 116 LEU THR PHE MET ASP SER SER GLY LEU GLY VAL ILE LEU SEQRES 6 D 116 GLY ARG TYR LYS GLN ILE LYS ASN VAL GLY GLY GLN MET SEQRES 7 D 116 VAL VAL CYS ALA VAL SER PRO ALA VAL LYS ARG LEU PHE SEQRES 8 D 116 ASP MET SER GLY LEU PHE LYS ILE ILE ARG VAL GLU ALA SEQRES 9 D 116 ASP GLU GLN PHE ALA LEU GLN ALA LEU GLY VAL ALA HET ADP A 200 27 HET DMF A 201 5 HET ADP C 201 27 HETNAM ADP ADENOSINE-5'-DIPHOSPHATE HETNAM DMF DIMETHYLFORMAMIDE FORMUL 5 ADP 2(C10 H15 N5 O10 P2) FORMUL 6 DMF C3 H7 N O FORMUL 8 HOH *53(H2 O) HELIX 1 1 ARG A 12 GLU A 14 5 3 HELIX 2 2 ASN A 15 ALA A 28 1 14 HELIX 3 3 GLN A 29 ASP A 31 5 3 HELIX 4 4 THR A 33 HIS A 54 1 22 HELIX 5 5 ASP A 88 ARG A 93 1 6 HELIX 6 6 MET A 108 MET A 117 1 10 HELIX 7 7 ASP B 23 ARG B 41 1 19 HELIX 8 8 ASP B 57 VAL B 74 1 18 HELIX 9 9 SER B 84 ASP B 92 1 9 HELIX 10 10 GLY B 95 ILE B 100 1 6 HELIX 11 11 ASP B 105 LEU B 113 1 9 HELIX 12 12 ARG C 12 GLU C 14 5 3 HELIX 13 13 ASN C 15 ALA C 28 1 14 HELIX 14 14 GLN C 29 ASP C 31 5 3 HELIX 15 15 THR C 33 HIS C 54 1 22 HELIX 16 16 ASP C 88 ARG C 93 1 6 HELIX 17 17 LYS C 100 GLU C 104 5 5 HELIX 18 18 MET C 108 MET C 117 1 10 HELIX 19 19 THR D 26 ARG D 41 1 16 HELIX 20 20 ASP D 57 ASN D 73 1 17 HELIX 21 21 SER D 84 SER D 94 1 11 HELIX 22 22 GLY D 95 ILE D 99 5 5 HELIX 23 23 ASP D 105 LEU D 113 1 9 SHEET 1 A10 GLU A 119 GLU A 125 0 SHEET 2 A10 GLY A 129 LYS A 135 -1 O TYR A 133 N ILE A 121 SHEET 3 A10 VAL A 74 ARG A 80 -1 N LEU A 77 O LEU A 134 SHEET 4 A10 ILE A 63 GLU A 71 -1 N ILE A 69 O HIS A 76 SHEET 5 A10 MET A 5 SER A 10 -1 N PHE A 9 O VAL A 64 SHEET 6 A10 ASN C 3 SER C 10 -1 O HIS C 6 N GLN A 8 SHEET 7 A10 ILE C 63 GLU C 71 -1 O VAL C 68 N MET C 5 SHEET 8 A10 VAL C 74 ARG C 80 -1 O THR C 78 N SER C 67 SHEET 9 A10 THR C 131 LYS C 136 -1 O VAL C 132 N VAL C 79 SHEET 10 A10 VAL C 122 GLU C 123 -1 N GLU C 123 O THR C 131 SHEET 1 B 5 LEU B 3 VAL B 9 0 SHEET 2 B 5 VAL B 13 LEU B 22 -1 O ARG B 17 N ASP B 6 SHEET 3 B 5 HIS B 45 MET B 56 1 O THR B 54 N GLY B 20 SHEET 4 B 5 MET B 78 CYS B 81 1 O VAL B 79 N LEU B 48 SHEET 5 B 5 ARG B 101 GLU B 103 1 O ARG B 101 N VAL B 80 SHEET 1 C 5 LEU D 3 LYS D 10 0 SHEET 2 C 5 VAL D 13 LEU D 22 -1 O ILE D 15 N GLU D 8 SHEET 3 C 5 HIS D 45 MET D 56 1 O PHE D 55 N LEU D 22 SHEET 4 C 5 MET D 78 CYS D 81 1 O VAL D 79 N LEU D 48 SHEET 5 C 5 ARG D 101 VAL D 102 1 O ARG D 101 N VAL D 80 SITE 1 AC1 17 ASN A 50 HIS A 54 GLY A 55 GLY A 85 SITE 2 AC1 17 ALA A 92 PHE A 97 THR A 98 THR A 99 SITE 3 AC1 17 ARG A 105 SER A 106 GLY A 107 GLY A 109 SITE 4 AC1 17 PHE A 110 THR A 130 HOH A 202 HOH A 213 SITE 5 AC1 17 HOH A 223 SITE 1 AC2 15 ASN C 50 HIS C 54 GLY C 55 ASP C 81 SITE 2 AC2 15 GLY C 85 ILE C 86 PHE C 97 THR C 98 SITE 3 AC2 15 THR C 99 ARG C 105 GLY C 107 GLY C 109 SITE 4 AC2 15 PHE C 110 THR C 130 HOH D 121 SITE 1 AC3 2 GLN A 29 GLU C 14 CRYST1 49.056 49.056 265.672 90.00 90.00 90.00 P 41 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020385 0.000000 0.000000 0.00000 SCALE2 0.000000 0.020385 0.000000 0.00000 SCALE3 0.000000 0.000000 0.003764 0.00000